JPMorgan Chase & Co’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 6114 |
|
|
2025
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 6374 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 6292 |
|
|
2024
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 6284 |
|
|
2024
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 6239 |
|
|
2024
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 6267 |
|
|
2023
Q4 | $4 | Sell |
1
-1
| -50% | -$4 | ﹤0.01% | 6415 |
|
|
2023
Q3 | $14 | Sell |
2
-85
| -98% | -$595 | ﹤0.01% | 6284 |
|
|
2023
Q2 | $810 | Buy |
87
+86
| +8,600% | +$801 | ﹤0.01% | 5579 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5943 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5725 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5638 |
|
|
2022
Q2 | $0 | Sell |
1
-277
| -100% | – | ﹤0.01% | 5722 |
|
|
2022
Q1 | $24K | Buy |
278
+50
| +22% | +$4.32K | ﹤0.01% | 5229 |
|
|
2021
Q4 | $21K | Hold |
228
| – | – | ﹤0.01% | 5310 |
|
|
2021
Q3 | $46K | Sell |
228
-77
| -25% | -$15.5K | ﹤0.01% | 4976 |
|
|
2021
Q2 | $142K | Buy |
+305
| New | +$142K | ﹤0.01% | 4639 |
|